How Privia Health Group, Inc. stacks up

PRVA · against 454 other Healthcare companies listed in US-listed

Growth

81/ 100

Above the middle of the pack.

Ranked #138 of 455 · scores higher than 69% of peers

Bars: peers in each 10-point band of the growth score

66 peers with a growth score of 80–89, including PRVA · Click a bar to see the companies

Why growth scores 81?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its earnings per share growth, revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.

faster revenue growth over three years: stronger than 76% of peers. 3-year revenue growth: 16.1% vs peer median 5.8%
faster revenue growth over the last year: stronger than 82% of peers. Revenue growth: 24.1% vs peer median 6.1%
faster growth in earnings per share: stronger than 84% of peers. Earnings per share growth: 82.1% vs peer median 9.8%

Metric by metric

Position: dot = PRVA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	PRVA	Peer median	Better than	Weight
Revenue growthHigher is better · 475 reported	24.1%	11.0%	70%	33%
Earnings per share growthHigher is better · 171 reported	82.1%	21.2%	78%	33%
3-year revenue growthHigher is better · 433 reported	16.1%	11.0%	60%	33%

Ranking by growth score

Top 5 and the companies ranked around PRVA

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
138	Lexicon Pharmaceuticals, Inc.LXRX · US-listed	650M USD	81	48
138	NeuroPace, Inc.NPCE · US-listed	423M USD	81	29
138	Owlet, Inc.OWLT · US-listed	124M USD	81	31
138	Phibro Animal Health CorporationPAHC · US-listed	1.5B USD	81	65
138	Privia Health Group, Inc.PRVA · US-listed	2.7B USD	81	56
138	SI-BONE, Inc.SIBN · US-listed	1.1B USD	81	50
145	Acadia Pharmaceuticals Inc.ACAD · US-listed	3.5B USD	80	75
145	Cronos Group Inc.CRON · US-listed	1.2B USD	80	67
145	Fortress Biotech, Inc.FBIOP · US-listed	Unavailable	80	56

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…